These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15370124)
1. A case of conjunctivitis associated with oral poliovirus type 2 vaccine (OPV). Jenkins R; Chiew YF; Langford D; Johns P; Huang S; Miller N Pathology; 2004 Oct; 36(5):505-6. PubMed ID: 15370124 [No Abstract] [Full Text] [Related]
2. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines. Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180 [TBL] [Abstract][Full Text] [Related]
3. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. Laassri M; Lottenbach K; Belshe R; Wolff M; Rennels M; Plotkin S; Chumakov K J Infect Dis; 2005 Dec; 192(12):2092-8. PubMed ID: 16288372 [TBL] [Abstract][Full Text] [Related]
4. World wide experience with inactivated poliovirus vaccine. Bonnet MC; Dutta A Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777 [TBL] [Abstract][Full Text] [Related]
5. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model. Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246 [TBL] [Abstract][Full Text] [Related]
6. Recovery of vaccinal poliovirus type 1 from conjunctiva of an infant with transient, unilateral conjunctivitis. Mirkovic RR; Lamberts DW; Dolen J Eur J Pediatr; 1985 Jul; 144(2):210-1. PubMed ID: 2995039 [No Abstract] [Full Text] [Related]
7. Evidence for a causal association between oral polio vaccine and transverse myelitis: A case history and review of the Literature. Kelly H J Paediatr Child Health; 2006 Apr; 42(4):155-9. PubMed ID: 16630313 [TBL] [Abstract][Full Text] [Related]
8. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Aylward RB J Infect Dis; 2009 Sep; 200(5):794-801. PubMed ID: 19624278 [TBL] [Abstract][Full Text] [Related]
9. Intrafamilial transmission of a Sabin 1-related poliovirus in Shizuoka Prefecture, Japan. Sugieda M; Adachi S; Inayoshi M; Masuda T; Tsubota M; Mano H; Iwama M; Murakami Y; Yoshida H; Shimizu H Jpn J Infect Dis; 2006 Aug; 59(4):277-8. PubMed ID: 16936354 [No Abstract] [Full Text] [Related]
10. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine. Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184 [TBL] [Abstract][Full Text] [Related]
11. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028 [TBL] [Abstract][Full Text] [Related]
12. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative. Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063 [TBL] [Abstract][Full Text] [Related]
13. Risk management in a polio-free world. Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391 [TBL] [Abstract][Full Text] [Related]
14. Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine. Martinez CV; Old MO; Kwock DK; Khan SS; Garcia JJ; Chan CS; Webster R; Falkovitz-Halpern MS; Maldonado YA J Infect Dis; 2004 Jul; 190(2):409-16. PubMed ID: 15216480 [TBL] [Abstract][Full Text] [Related]
16. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. Adu F; Iber J; Bukbuk D; Gumede N; Yang SJ; Jorba J; Campagnoli R; Sule WF; Yang CF; Burns C; Pallansch M; Harry T; Kew O Virus Res; 2007 Jul; 127(1):17-25. PubMed ID: 17449127 [TBL] [Abstract][Full Text] [Related]
17. Oral poliovaccine: will it help eradicate polio or cause the next epidemic? Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568 [TBL] [Abstract][Full Text] [Related]
20. Investigations of clinical isolations of oral poliovirus vaccine strains between 2000 and 2005 in southern Taiwan. Chi CY; Tseng FC; Liu DP; Chang YW; Wu HC; Huang YF; Hwang KP; Hsu YW; Wang SM; Liu CC; Wu HS; Yang JY; Yang CF; Wang JR; Su IJ J Clin Virol; 2009 Jun; 45(2):129-34. PubMed ID: 19394265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]